A recent meta-analysis of RCTs in patients with diabetes concluded that the presence or absence of ASCVD does not modify the association of SGLT2-is with MACEs, CV deaths, and HHF, respectively (McGuire et al., 2021). This evidence concerns the gene SLC5A2 and diabetes mellitus.